In gene therapy studies, first generation replicationdefective adenoviral vectors have proven to be highly effective as vehicles for delivery and expression of foreign genes. They are able to infect a large variety of dividing and post-mitotic cells both in vitro and in vivo, and have other very attractive properties, such as ease of purification, high titers and long-term storage stability. 1 Typically, strong and ubiquitously active viral promoters from human cytomegalovirus (HCMV) and Rous sarcoma virus (RSV) have been used to drive transgene expression in both diagnostic and clinical studies. However, this approach has several important disadvantages. First, there are tissues and cell types in which these promoters are not highly active, [2] [3] [4] and in some tissues where they are initially active that activity is gradually 'silenced' or 'shut off' through as yet unidentified cellular mechanisms. 5 Second, it has recently been shown that high levels of transgene expression in certain antigen-presenting cells significantly increase the response of the host immune system to that transgene, thereby limiting vector efficacy. 6, 7 Third, for cancer therapy strategies that utilize adenoviral vectors to deliver cytotoxic genes to tumor cells, selectively restricting the expression of these transgenes to their target cells is clearly desirable. mids containing the terminal repeat sequences of Ad5 with or without the E1A enhancer. Subsequently, adenoviral vectors were constructed containing identical expression units either in the E1 region or near the right ITR, and tested in several cell lines. Here, we report that promoters placed near the right ITR of Ad5 retain higher selectivity and lower background expression in both plasmid and adenovirus vectors. We confirm that the E1A enhancer can interfere with the desired activity of nearby promoters, and describe an alternative transgene insertion site for construction of Ad vectors. Gene Therapy (2001) 8, 247-253.
A strategy known as transcriptional targeting has been developed to overcome these problems. 8 It utilizes tissuespecific promoters to express selectively the transgenes in target cells. Several studies have described successful application of this approach when the expression cassette is delivered by an adenoviral vector. [9] [10] [11] [12] [13] However, selective activity of some promoters -that have been originally characterized as highly specific -was altered or lost when they were placed in the context of adenoviral genome. [14] [15] [16] [17] A hypothesis advanced to explain this phenomenon postulated that enhancer elements and/or cryptic transcription start sites within the adenoviral sequences surrounding the transgene expression cassette were interacting with the promoter elements to activate 'illicit' transcription in nontarget cells. Enhancer activity has been reported for such Ad5 sequences as the inverted terminal repeats (ITR), 18 E2 and E4 promoters, 19, 20 the pIX promoter 17 and the E1A enhancer. 21 That adenoviral elements can exert a powerful influence on the activity of the promoter inserted in the E1 region has recently been demonstrated in a study where insulator elements around the transgene cassette significantly improved the performance of an inducible promoter. 22 Among the Ad sequences suspected of promoter interference, the activity of the E1A enhancer is by far the best characterized. For example, previous studies have shown that this enhancer (nt 190-320) is active in most cell types tested and stimulates transcription of E1A (as well as other adenoviral early genes) three-to five-fold. 23, 24 In addition, the region appears to contain 'cryptic' transcrip-tion initiation sites which may contribute significantly to promoter interference. 25 Since the majority of adenoviral vectors in use today replace the E1 region with the transgene expression cassette which places the promoter in close proximity to the E1A enhancer region, it is not unreasonable to assume that some modulation of transcriptional activity would result. The E1A enhancer overlaps the sequences required for packaging of Ad5 26 and therefore cannot be easily removed.
We hypothesized that the E1A enhancer provides the bulk of the activity that interferes with cell type-specific promoters, and that placing these promoters (and the genes they drive) as far away from the E1 region as possible could significantly improve their performance. If successful, this approach would be of some benefit in the construction of adenovirus vectors with tissue-specific or regulatable promoters, since it would avoid the use of bulky insulator elements which may also have a negative effect on the overall promoter activity. 22 In order to determine what effect the E1A enhancer and other Ad sequences may have on the activity of tet-regulated or prostate-specific promoters, we have transiently transfected three cultured cell lines with three series of plasmid constructs: one with the left ITR and E1A enhancer (pL-Ad series), one with the E4 promoter and the right ITR (pR-Ad series), and one based on the pSEAP2-Basic vector (Clontech, Palo Alto, CA, USA) without any Ad sequences ( Figure 1a) . Each series contained vectors with TRE, ARR2PB and ⌬PSE promoters driving the expression of SEAP reporter protein, which is translated and secreted into the culture media at the rate proportional to the transcription of its gene. 20, 27 All vector series contained a transcription blocker element (TB; from pSEAP2-Basic) upstream of the promoter to prevent interference from upstream transcription elements, 28 and therefore should be affected only by the long-range enhancer activity. All vectors were purified using Qiagen Plasmid Midi Kit (Qiagen, Valencia, CA, USA) and their DNA concentrations were equalized in order to minimize variability in transfection efficiencies. We have determined the levels of SEAP secreted into culture media over the 24 h period for cells transfected with each test construct.
The ARR2PB (0.45 kb) promoter was developed in the laboratory of Dr Robert J Matusik (Department of Cell Biology, Vanderbilt University Medical Center, Nashville, TN, USA), who kindly contributed the pARR2PB.PolI.TRZ-SK vector. ARR2PB is based on the minimal probasin promoter with a duplicated probasin androgen response region (ARR) upstream of it. 29 In transgenic mouse studies, it has been characterized as very strong with prostate-limited expression (R Matusik, personal communication). Prostate secreted antigen (PSA) promoter and upstream regulatory region to −5831 was PCR-amplified from PC3 cells using the upper (5Ј-CGGTGACATCGTGGAAAGCA-3Ј) and lower (5Ј-GGA-CAGGGTGAGGAAGACAA-3Ј) primers, and cloned into pGEM*T-Easy (Invitrogen, Carlsbad, CA, USA). Subsequently, sequences between −3738 and −541 (relative to the start of transcription of the PSA gene) were deleted to generate pPSA.FRAG-T-Easy, which contains ⌬PSE promoter. This was done to reduce promoter size without affecting transcriptional activity. 30 The pPSA.FRAG-TEasy vector was a generous gift from Dr David Kurtz (Department of Pharmacology, MUSC).
Negligible SEAP activity was detected in HeLa (cervical epithelial cancer cell line, ATCC, Manassas, VA, USA) and A549 (lung adenocarcinoma cell line; ATCC) cells transfected with ARR2PB and ⌬PSE constructs (Figure 2a ), as was expected for these highly prostate cellspecific promoters which require the presence of functional androgen receptor for activity. Nevertheless, SEAP activity was somewhat higher in the pL-Ad background compared with the pR-Ad and Basic construct series, suggesting that the presence of the E1A enhancer was acting to increase promoter activity. In androgen-responsive LNCaP (prostate cancer cell line; Urocor, Oklahoma City, OK, USA) cells, the activity of ARR2PB was comparable with that of the CMV promoter (approximately 60% in Basic vector background; Figure 2b ), while that of ⌬PSE was significantly less (8-9% of CMV; Figure 2b ) but comparable with the previously reported activity of PSE/PSA promoter. 30 Both promoters had higher activity in pL-Ad vector than in either Basic or pR-Ad backgrounds. In general, both of these promoters were very specific to prostate-derived androgen receptor-expressing LNCaP cells, so that the effect of the E1A enhancer, while detectable with a sensitive SEAP assay, did not substantially increase their basal activity above background.
The pUHD10-3 vector containing the TRE promoter was generously provided by Dr H Bujard (Center for Molecular Biology, University of Heidelberg, Germany). The TRE element (0.43 kb) consists of the minimal CMV promoter (−53 relative to the transcription start site) and seven operator sites for the E. coli tetracycline repressor upstream of it. 31 These bacterial sequences should not, in principle, have any transcription initiating or enhancer activity in mammalian cells. Therefore, this promoter can be considered an 'enhancer trap'. TRE-driven SEAP activity in Basic vector background was significantly higher than that of the prostate-specific promoters in A549 and HeLa (Figure 2c ). This activity was essentially unchanged in the pR-Ad vector background, suggesting that the E4 promoter and the right ITR of Ad5 contribute little to the promoter interference, at least in the context of this experiment. In pL-Ad vector, TRE-mediated SEAP activity was significantly higher, ranging from four-to seven-fold above that in the pR-Ad and Basic vectors (Figure 2c) .
We have also constructed pL-Ad and pR-Ad vectors with the TRE expression cassette inserted in the reverse orientation (pL-Ad-(T.SP) R and pR-Ad-(T.SP) R , Figure  1a ). Transfection with pL-Ad-(T.SP) R vector produced a somewhat lower SEAP activity then the pL-Ad-T.SP vector (with the TRE-SEAP expression cassette in the forward orientation), but the difference was much less than the one observed between this construct and pR-Ad-T.SP (Figure 2c ). We interpret this result to mean that the effect of the E1A enhancer extends over long tracts of sequence, but that its influence gradually diminishes. However, the effect of reversing expression unit orientation that we have observed is minor when compared with the result of similar manipulation reported by Steinwaerder and Lieber. 22 When their metal-responsive MRE promoter was cloned in the forward orientation (with respect to 5ЈAd) in the E1 region, its uninduced activity was almost as high as the induced one, while cloning it in the reverse orientation decreased uninduced transgene expression 10-fold. However, that study did not distinguish between the enhancer interference and 'cryptic' transcription known to initiate from the E1A region, 25 so it is possible that the orientation effect was due to the transcriptional interference in the forward orientation.
In order to examine the effect of E1 versus E4 location and the expression cassette orientation on the induced and undinduced activity of the TRE promoter, we have assembled in vitro full-length genomes of Ad5 vectors containing the TRE-SEAP unit in the E1 cloning site in both forward and reverse orientation and also containing the tTA tet transactivator protein under the control of the Gene Therapy CMV promoter in the E4 region of both constructs. Also, Ad5 vector genomes were assembled with CMV-tTA in the E1 region and TRE-SEAP in the E4 cloning site in both forward and reverse orientations. These genomes were gel-purified and transfected into A549, HeLa and LNCaP cells as described in Figure 3 . Activity of the TRE promoter is induced to high levels by the binding of the tet transactivator fusion protein, which is expressed from the same DNA construct. That induction can be reversed by the addition of the tetracycline analog doxycycline 
(CCS) from HyClone (Logan, UT, USA) and 1% penicillin/streptomycin (Mediatech). On the next day, cells were transfected with 1 g of plasmid constructs (pBasic, pL-Ad and pR-Ad series of constructs containing SEAP gene and various promoters) per well using SuperFect reagent (Qiagen) according to the manufacturer's instructions. Control wells were transfected with pL-Ad-C.Gf.B construct and transfection efficiency was monitored by visualizing GFP fluorescence in cells after 24 h using an Axiovert-25 fluorescent microscope (Zeiss Optical Systems, Thornwood, NY, USA) and FITC excitation/emission filter set (Chroma Technology Corp, Brattleboro, VT, USA). After 24 h, culture medium was removed, cells were washed with 1 × PBS and 1 ml of serumfree RPMI 1640 media with 10 nm dihydrotestosterone (DHT; Sigma) was added to each well. After another 24 h, 200 l samples of culture media were collected and frozen. SEAP activity was determined using the Great EscAPe chemiluminescence detection kit (Clontech) according to the manufacturer's instructions and using AutoLumat LB953 luminometer (EG&G, Gaithersburg, MD, USA). Shown is the average SEAP activity in relative luminescence units ± s.e.m. (n = 4). Numbers to the right of the graphs indicate the ratios of pL-Ad activity over that of pR-Ad once cell background has been subtracted from both.
(Sigma) which prevents tTA binding to the tet operator sites in the TRE. 31 We have found that TRE activity in the presence of doxycycline (uninduced) was significantly higher when the promoter was located in the E1 region as compared with the E4 location (Figure 3) , consistent with the findings described above. However, in this experiment, no significant effect of TRE orientation (forward or reverse) within either the E1 or the E4 cloning sites was observed. Under the induced conditions, high SEAP expression levels were obtained with all vectors, with no significant differences attributable to either location or the orientation of the expression cassette (Figure 3 ). When the TRE activity was analyzed as a ratio of induced to uninduced activity, higher induction levels were observed for the E4 location of the expression cassette, but again no significant effect of orientation was seen in either cloning site (Figure 3) . It would appear that in the context of full-length Ad5 genome, proximity to the E1A enhancer is still the major determinant of enhancer interference with the basal promoter activity, with the other sequences playing a minor role at best. Our observations are in agreement with the classical enhancer definition, ie an element with transcription upregulating activity which is orientation independent and extends over significant distances of DNA sequence. The E1A enhancer did not appear to have a significant effect on the induced activity of the TRE promoter, which is consistent with the model that the combination of the enhancer activity of E1A and TRE is additive rather than synergistic. The fact that the regulatory sequences of E4 promoter had no detectable effect on the activity of the TRE promoter is not surprising, since in the absence of E1a protein the activity of the E4 promoter is suppressed. 23 We wished to evaluate the effect of promoter position on its activity in the context of functional adenovirus vectors. Recently, we have developed adenovirus vector construction methods that allow an insertion of a transgene expression cassette between the right ITR and the E4 promoter of Ad5. 32 We chose the TRE promoter, which has significant background activity and was affected by the E1A enhancer in transient transfection studies. This promoter is also of interest because it is a component of a popular tet-regulatable expression system which has already been utilized in the context of Ad vectors. 33 We also wanted to test the ARR2PB promoter, which is the strongest prostate-specific promoter known to date and is as prostate cell specific as the ⌬PSE promoter ( Figure  2a and b) . Shuttle vectors pL-Ad-T.SP, pL-Ad-2Pb.SP, pRAd-T.SP and pR-Ad-2Pb.SP were used to generate Ad vectors with the SEAP expression cassette inserted into the E1 site (L-Ad vectors) or the E4/R-ITR site (R-Ad). Construction of pL-Ad-CMV, pL-Ad-C.Gf and pR-Admcs vectors was previously described. 32 A BGH polyA signal site from pcDNA3(−) (Invitrogen) was PCR-amplified and cloned into pL-Ad-C.Gf to produce pL-Ad-C.Gf.B. A CMV promoter-GFP-BGHpA expression cassette was taken from that construct and inserted into pRAd-mcs to generate pR-Ad-C.Gf.B. Vectors pL-Ad-C.GF.B and pR-Ad-C.GF.B were used to insert a CMV-GFP expression cassette into the site opposite that of the SEAP cassette. The genomes of recombinant Ad vectors were assembled in vitro and transfected into 293 cells as previously described. 32 The cultures were propagated until virus-induced cytopathic effects (CPE) were observed. Primary vector stocks were amplified according to established techniques, banded twice using CsCl gradient ultracentrifugation and dialyzed against 1 × PBS. Vectors were titrated on 293 cells based on GFP fluorescence, and the titers were scored as infectious par- The level of protein expression depends not only on the promoter activity, but also on the copy number of the promoter and gene within the nucleus of the cell. With that in mind, we adjusted the MOI of our vectors so that on average between 30% and 60% of cells were transduced. Under these conditions, most of the infected cells would receive one or at most two copies of the expression cassette. We determined the fraction of transduced cells per well by flow cytometry using GFP fluorescence, and Gene Therapy this information was used to normalize SEAP activity between wells.
The rAd.T-S/C-G vector, with the TRE-SEAP cassette in the E1 region, consistently generated more SEAP activity then the rAd.C-G/T-S (Figure 4a) . The difference ranged from 3.8-fold in LNCaP cells to eight-fold in A549, with an average of 6.1-fold for all three cell lines ( Figure  4a ). This value is in good agreement with the averaged difference between pL-Ad and pR-Ad TRE-SEAP constructs of 5.1-fold. It would seem that if the additional Ad5 regulatory elements not present in the pL-Ad and pR-Ad plasmids (such as pIX, MLP, E3 and E2 promoters) have an effect on the TRE activity, they contribute equally to both left and right promoter cloning sites.
The activity of the rAd.P-S/C-G vector was higher than that of the Ad.C-G/P-S vector in HeLa and A549 cells, 2.1 and 2.9-fold, respectively (Figure 4b) . These values are again similar to those obtained in the transient transfection experiments (1.9-fold, Figure 2a) , which, in combination with the overall negligible activity of this promoter in non-prostate cell lines (as compared with the activity of both constructs in LNCaP cells, Figure 4b ), supports the hypothesis that the ARR2PB is not significantly affected by the adenovirus regulatory sequences. However, the E1A enhancer effect does exist and becomes more apparent as the MOI of A549 cells with ARR2PB-SEAP vectors is increased (Figure 4c) . A similar expression pattern was seen with HeLa cells (data not shown). Overall, SEAP activity increases with increasing MOI, underlining the fact that even stringent tissue-specific promoters can have a significant level of background expression in a non-permissive cell type if multiple copies of the expression cassette are present in the cell.
In conclusion, we have confirmed that a small but sig-nificant enhancer effect exists near the packaging signal of adenovirus type 5 and interacts with the regulatory transcription elements cloned in its vicinity. The data presented here demonstrate that placing a promoter in close proximity to the E1A enhancer results in a severalfold increase in transgene expression as compared with the cloning site near the right ITR. This effect is distinct from the 'cryptic' transcription initiation also found in that region, 25 and in the absence of vector replication accounts for most of the enhancer-type promoter interference found in adenovirus vectors. When selective transgene expression is desirable, this effect may be minimized by cloning the transgenes with tissue-specific or regulatable promoters into the region near the right ITR, which is an alternative possible using our vector assembly strategy.
